Research Costs. During the Research Term, Roche shall fund the work to be performed at Pieris for the Research Plan at the FTE Rate as specified in the Agreement. Roche shall pay to Pieris such work to be performed during the Research Term, [***], within [***] after receiving a corresponding invoice from Pieris, corresponding to the [***] for such [***] according to the Research Plan (as it may be amended from time to time through the JRC). Within thirty (30) days after the end of each Calendar Quarter during the Research Term, Pieris shall provide to Roche a document specifying [***] and [***] incurred by Pieris during such Calendar Quarter. Any overpayment from Roche shall be credited to the invoice for the next quarter. Any underpayment from Roche shall be added to the invoice for the next quarter.
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Pieris Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Pieris Pharmaceuticals, Inc.), Research Collaboration and License Agreement (Pieris Pharmaceuticals, Inc.)